ニュース

最新ニュース

論文掲載のお知らせ：世界初となる”U-to-C”の遺伝子編集をヒト細胞で実現しました

EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells

Philippe De Backer joins Newton Biocapital as a Senior Partner

Sequana Medical announces H1 2022 results and provides business update

SYNERGIA MEDICAL SUCCESSFULLY RAISES SERIES B FUNDING OF €9 MILLION

Alexandra Clyde appointed to Sequana Medical Board of Directors

Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke

Doug Kohrs appointed to Sequana Medical Board of Directors

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

7
8
9
10
11